Literature DB >> 7346532

Prolonged maintenance interval in hymenoptera venom immunotherapy.

D B Golden, A Kagey-Sobotka, M D Valentine, L M Lichtenstein.   

Abstract

To decrease the cost, inconvenience, and potential side effects of venom immunotherapy we tested whether the interval between the maintenance injections can be increased. In 30 patients who had been given the standard therapy regimen and who had been sting-challenged after 1 and 2 yr of monthly maintenance injections the maintenance interval was increased from 4 to 6 wk. IgG anti-yellow jacket venom antibodies did not change over the next 9 mo. The incidence of local reactions to venom injections did not increase, and there were no systemic reactions during therapy. After 6 to 9 mo 29 of the 30 patients were sting-challenged with one possible reaction. The success rate, 97%, is the same as that observed with monthly maintenance injections. We conclude that the 6-wk maintenance interval is effective in both clinical and immunologic terms after a period of monthly maintenance therapy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7346532     DOI: 10.1016/0091-6749(81)90102-0

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  5 in total

1.  The sting.

Authors:  J H Day
Journal:  Can Fam Physician       Date:  1982-04       Impact factor: 3.275

Review 2.  Venom immunotherapy: an updated review.

Authors:  Darío Antolín-Amérigo; Carmen Moreno Aguilar; Arantza Vega; Melchor Alvarez-Mon
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

3.  Venom immunotherapy for stinging insect allergy.

Authors:  D F Graft
Journal:  Clin Rev Allergy       Date:  1987-05

4.  Allergy to insect stings: a review.

Authors:  P W Ewan
Journal:  J R Soc Med       Date:  1985-03       Impact factor: 5.344

5.  Management of insect sting hypersensitivity: an update.

Authors:  Robert D Pesek; Richard F Lockey
Journal:  Allergy Asthma Immunol Res       Date:  2013-02-25       Impact factor: 5.764

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.